Diabetes can severely damage the heart, blood vessels, eyes, kidneys and nerves. A diabetes assay is used to diagnose and monitor people at risk for developing diabetes.
LPI (LP Information)' newest research report, the “Diabetic Assays Industry Forecast” looks at past sales and reviews total world Diabetic Assays sales in 2022, providing a comprehensive analysis by region and market sector of projected Diabetic Assays sales for 2023 through 2029. With Diabetic Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diabetic Assays industry.
This Insight Report provides a comprehensive analysis of the global Diabetic Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diabetic Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diabetic Assays market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diabetic Assays and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diabetic Assays.
The global Diabetic Assays market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Diabetic Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Diabetic Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Diabetic Assays is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Diabetic Assays players cover InSphero, Abbott Laboratories, American Laboratory Products Company, Danaher Corporation, Bio RAD laboratories, Ortho Clinical Diagnostics, Roche, Siemens and PTS Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Assays market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Enzymatic Assay
Colorimetric Assay
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
InSphero
Abbott Laboratories
American Laboratory Products Company
Danaher Corporation
Bio RAD laboratories
Ortho Clinical Diagnostics
Roche
Siemens
PTS Diagnostics

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Diabetic Assays Market Size 2018-2029 2.1.2 Diabetic Assays Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Diabetic Assays Segment by Type 2.2.1 Enzymatic Assay 2.2.2 Colorimetric Assay 2.2.3 Others 2.3 Diabetic Assays Market Size by Type 2.3.1 Diabetic Assays Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Diabetic Assays Market Size Market Share by Type (2018-2023) 2.4 Diabetic Assays Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.4.3 Others 2.5 Diabetic Assays Market Size by Application 2.5.1 Diabetic Assays Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Diabetic Assays Market Size Market Share by Application (2018-2023) 3 Diabetic Assays Market Size by Player 3.1 Diabetic Assays Market Size Market Share by Players 3.1.1 Global Diabetic Assays Revenue by Players (2018-2023) 3.1.2 Global Diabetic Assays Revenue Market Share by Players (2018-2023) 3.2 Global Diabetic Assays Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Diabetic Assays by Regions 4.1 Diabetic Assays Market Size by Regions (2018-2023) 4.2 Americas Diabetic Assays Market Size Growth (2018-2023) 4.3 APAC Diabetic Assays Market Size Growth (2018-2023) 4.4 Europe Diabetic Assays Market Size Growth (2018-2023) 4.5 Middle East & Africa Diabetic Assays Market Size Growth (2018-2023) 5 Americas 5.1 Americas Diabetic Assays Market Size by Country (2018-2023) 5.2 Americas Diabetic Assays Market Size by Type (2018-2023) 5.3 Americas Diabetic Assays Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Diabetic Assays Market Size by Region (2018-2023) 6.2 APAC Diabetic Assays Market Size by Type (2018-2023) 6.3 APAC Diabetic Assays Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Diabetic Assays by Country (2018-2023) 7.2 Europe Diabetic Assays Market Size by Type (2018-2023) 7.3 Europe Diabetic Assays Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Diabetic Assays by Region (2018-2023) 8.2 Middle East & Africa Diabetic Assays Market Size by Type (2018-2023) 8.3 Middle East & Africa Diabetic Assays Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Diabetic Assays Market Forecast 10.1 Global Diabetic Assays Forecast by Regions (2024-2029) 10.1.1 Global Diabetic Assays Forecast by Regions (2024-2029) 10.1.2 Americas Diabetic Assays Forecast 10.1.3 APAC Diabetic Assays Forecast 10.1.4 Europe Diabetic Assays Forecast 10.1.5 Middle East & Africa Diabetic Assays Forecast 10.2 Americas Diabetic Assays Forecast by Country (2024-2029) 10.2.1 United States Diabetic Assays Market Forecast 10.2.2 Canada Diabetic Assays Market Forecast 10.2.3 Mexico Diabetic Assays Market Forecast 10.2.4 Brazil Diabetic Assays Market Forecast 10.3 APAC Diabetic Assays Forecast by Region (2024-2029) 10.3.1 China Diabetic Assays Market Forecast 10.3.2 Japan Diabetic Assays Market Forecast 10.3.3 Korea Diabetic Assays Market Forecast 10.3.4 Southeast Asia Diabetic Assays Market Forecast 10.3.5 India Diabetic Assays Market Forecast 10.3.6 Australia Diabetic Assays Market Forecast 10.4 Europe Diabetic Assays Forecast by Country (2024-2029) 10.4.1 Germany Diabetic Assays Market Forecast 10.4.2 France Diabetic Assays Market Forecast 10.4.3 UK Diabetic Assays Market Forecast 10.4.4 Italy Diabetic Assays Market Forecast 10.4.5 Russia Diabetic Assays Market Forecast 10.5 Middle East & Africa Diabetic Assays Forecast by Region (2024-2029) 10.5.1 Egypt Diabetic Assays Market Forecast 10.5.2 South Africa Diabetic Assays Market Forecast 10.5.3 Israel Diabetic Assays Market Forecast 10.5.4 Turkey Diabetic Assays Market Forecast 10.5.5 GCC Countries Diabetic Assays Market Forecast 10.6 Global Diabetic Assays Forecast by Type (2024-2029) 10.7 Global Diabetic Assays Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 InSphero 11.1.1 InSphero Company Information 11.1.2 InSphero Diabetic Assays Product Offered 11.1.3 InSphero Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 InSphero Main Business Overview 11.1.5 InSphero Latest Developments 11.2 Abbott Laboratories 11.2.1 Abbott Laboratories Company Information 11.2.2 Abbott Laboratories Diabetic Assays Product Offered 11.2.3 Abbott Laboratories Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Abbott Laboratories Main Business Overview 11.2.5 Abbott Laboratories Latest Developments 11.3 American Laboratory Products Company 11.3.1 American Laboratory Products Company Company Information 11.3.2 American Laboratory Products Company Diabetic Assays Product Offered 11.3.3 American Laboratory Products Company Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 American Laboratory Products Company Main Business Overview 11.3.5 American Laboratory Products Company Latest Developments 11.4 Danaher Corporation 11.4.1 Danaher Corporation Company Information 11.4.2 Danaher Corporation Diabetic Assays Product Offered 11.4.3 Danaher Corporation Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Danaher Corporation Main Business Overview 11.4.5 Danaher Corporation Latest Developments 11.5 Bio RAD laboratories 11.5.1 Bio RAD laboratories Company Information 11.5.2 Bio RAD laboratories Diabetic Assays Product Offered 11.5.3 Bio RAD laboratories Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Bio RAD laboratories Main Business Overview 11.5.5 Bio RAD laboratories Latest Developments 11.6 Ortho Clinical Diagnostics 11.6.1 Ortho Clinical Diagnostics Company Information 11.6.2 Ortho Clinical Diagnostics Diabetic Assays Product Offered 11.6.3 Ortho Clinical Diagnostics Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Ortho Clinical Diagnostics Main Business Overview 11.6.5 Ortho Clinical Diagnostics Latest Developments 11.7 Roche 11.7.1 Roche Company Information 11.7.2 Roche Diabetic Assays Product Offered 11.7.3 Roche Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Roche Main Business Overview 11.7.5 Roche Latest Developments 11.8 Siemens 11.8.1 Siemens Company Information 11.8.2 Siemens Diabetic Assays Product Offered 11.8.3 Siemens Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Siemens Main Business Overview 11.8.5 Siemens Latest Developments 11.9 PTS Diagnostics 11.9.1 PTS Diagnostics Company Information 11.9.2 PTS Diagnostics Diabetic Assays Product Offered 11.9.3 PTS Diagnostics Diabetic Assays Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 PTS Diagnostics Main Business Overview 11.9.5 PTS Diagnostics Latest Developments 12 Research Findings and Conclusion